169 related articles for article (PubMed ID: 19401473)
1. Effects of Ginkgo biloba extract ingestion on the pharmacokinetics of talinolol in healthy Chinese volunteers.
Fan L; Tao GY; Wang G; Chen Y; Zhang W; He YJ; Li Q; Lei HP; Jiang F; Hu DL; Huang YF; Zhou HH
Ann Pharmacother; 2009 May; 43(5):944-9. PubMed ID: 19401473
[TBL] [Abstract][Full Text] [Related]
2. Effect of Schisandra chinensis extract and Ginkgo biloba extract on the pharmacokinetics of talinolol in healthy volunteers.
Fan L; Mao XQ; Tao GY; Wang G; Jiang F; Chen Y; Li Q; Zhang W; Lei HP; Hu DL; Huang YF; Wang D; Zhou HH
Xenobiotica; 2009 Mar; 39(3):249-54. PubMed ID: 19280523
[TBL] [Abstract][Full Text] [Related]
3. Grapefruit juice ingestion significantly reduces talinolol bioavailability.
Schwarz UI; Seemann D; Oertel R; Miehlke S; Kuhlisch E; Fromm MF; Kim RB; Bailey DG; Kirch W
Clin Pharmacol Ther; 2005 Apr; 77(4):291-301. PubMed ID: 15903127
[TBL] [Abstract][Full Text] [Related]
4. Unexpected effect of concomitantly administered curcumin on the pharmacokinetics of talinolol in healthy Chinese volunteers.
Juan H; Terhaag B; Cong Z; Bi-Kui Z; Rong-Hua Z; Feng W; Fen-Li S; Juan S; Jing T; Wen-Xing P
Eur J Clin Pharmacol; 2007 Jul; 63(7):663-8. PubMed ID: 17468862
[TBL] [Abstract][Full Text] [Related]
5. Lack of effect of continuous glycyrrhizin administration on the pharmacokinetics of the P-glycoprotein substrate talinolol in healthy volunteers.
Yan M; Fang PF; Li HD; Xu P; Liu YP; Wang F; Cai HL; Tan QY
Eur J Clin Pharmacol; 2013 Mar; 69(3):515-21. PubMed ID: 22983284
[TBL] [Abstract][Full Text] [Related]
6. Effect of Ginkgo biloba extract on lopinavir, midazolam and fexofenadine pharmacokinetics in healthy subjects.
Robertson SM; Davey RT; Voell J; Formentini E; Alfaro RM; Penzak SR
Curr Med Res Opin; 2008 Feb; 24(2):591-9. PubMed ID: 18205997
[TBL] [Abstract][Full Text] [Related]
7. Effect of continuous silymarin administration on oral talinolol pharmacokinetics in healthy volunteers.
Han Y; Guo D; Chen Y; Tan ZR; Zhou HH
Xenobiotica; 2009 Sep; 39(9):694-9. PubMed ID: 19555315
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of talinolol is modified by barnidipine: implication of P-glycoprotein modulation.
Ozturk N; Ozturk D; Pala-Kara Z; Okyar A
Pharmazie; 2017 Jan; 72(1):29-34. PubMed ID: 29441894
[TBL] [Abstract][Full Text] [Related]
9. MDR1 genotype do not influence the absorption of a single oral dose of 100 mg talinolol in healthy Chinese males.
Zhang WX; Chen GL; Zhang W; Tan ZR; Liu J; Zhou G; Hu DL; Zhou HH
Clin Chim Acta; 2005 Sep; 359(1-2):46-52. PubMed ID: 16170863
[TBL] [Abstract][Full Text] [Related]
10. Grapefruit juice enhances intestinal absorption of the P-glycoprotein substrate talinolol.
Spahn-Langguth H; Langguth P
Eur J Pharm Sci; 2001 Feb; 12(4):361-7. PubMed ID: 11231102
[TBL] [Abstract][Full Text] [Related]
11. Simvastatin does not influence the intestinal P-glycoprotein and MPR2, and the disposition of talinolol after chronic medication in healthy subjects genotyped for the ABCB1, ABCC2 and SLCO1B1 polymorphisms.
Bernsdorf A; Giessmann T; Modess C; Wegner D; Igelbrink S; Hecker U; Haenisch S; Cascorbi I; Terhaag B; Siegmund W
Br J Clin Pharmacol; 2006 Apr; 61(4):440-50. PubMed ID: 16542205
[TBL] [Abstract][Full Text] [Related]
12. Effect of bifendate on the pharmacokinetics of talinolol in healthy subjects.
Zeng Y; He FY; He YJ; Dai LL; Fan L; Zhou HH
Xenobiotica; 2009 Nov; 39(11):844-9. PubMed ID: 19845435
[TBL] [Abstract][Full Text] [Related]
13. Stereoselective disposition of talinolol in man.
Zschiesche M; Lemma GL; Klebingat KJ; Franke G; Terhaag B; Hoffmann A; Gramatté T; Kroemer HK; Siegmund W
J Pharm Sci; 2002 Feb; 91(2):303-11. PubMed ID: 11835190
[TBL] [Abstract][Full Text] [Related]
14. P-glycoprotein inhibitor erythromycin increases oral bioavailability of talinolol in humans.
Schwarz UI; Gramatté T; Krappweis J; Oertel R; Kirch W
Int J Clin Pharmacol Ther; 2000 Apr; 38(4):161-7. PubMed ID: 10783825
[TBL] [Abstract][Full Text] [Related]
15. Effects of Ginkgo biloba extracts on pharmacokinetics and efficacy of atorvastatin based on plasma indices.
Guo CX; Pei Q; Yin JY; Peng XD; Zhou BT; Zhao YC; Wu LX; Meng XG; Wang G; Li Q; Ouyang DS; Liu ZQ; Zhang W; Zhou HH
Xenobiotica; 2012 Aug; 42(8):784-90. PubMed ID: 22381135
[TBL] [Abstract][Full Text] [Related]
16. Unexpected effect of verapamil on oral bioavailability of the beta-blocker talinolol in humans.
Schwarz UI; Gramatté T; Krappweis J; Berndt A; Oertel R; von Richter O; Kirch W
Clin Pharmacol Ther; 1999 Mar; 65(3):283-90. PubMed ID: 10096260
[TBL] [Abstract][Full Text] [Related]
17. Effects of Ginkgo biloba extracts on diazepam metabolism: a pharmacokinetic study in healthy Chinese male subjects.
Zuo XC; Zhang BK; Jia SJ; Liu SK; Zhou LY; Li J; Zhang J; Dai LL; Chen BM; Yang GP; Yuan H
Eur J Clin Pharmacol; 2010 May; 66(5):503-9. PubMed ID: 20186406
[TBL] [Abstract][Full Text] [Related]
18. High-dose short-term administration of naringin did not alter talinolol pharmacokinetics in humans.
Nguyen MA; Staubach P; Tamai I; Langguth P
Eur J Pharm Sci; 2015 Feb; 68():36-42. PubMed ID: 25486333
[TBL] [Abstract][Full Text] [Related]
19. Induction of intestinal P-glycoprotein by St John's wort reduces the oral bioavailability of talinolol.
Schwarz UI; Hanso H; Oertel R; Miehlke S; Kuhlisch E; Glaeser H; Hitzl M; Dresser GK; Kim RB; Kirch W
Clin Pharmacol Ther; 2007 May; 81(5):669-78. PubMed ID: 17392718
[TBL] [Abstract][Full Text] [Related]
20. Oral bioavailability of digoxin is enhanced by talinolol: evidence for involvement of intestinal P-glycoprotein.
Westphal K; Weinbrenner A; Giessmann T; Stuhr M; Franke G; Zschiesche M; Oertel R; Terhaag B; Kroemer HK; Siegmund W
Clin Pharmacol Ther; 2000 Jul; 68(1):6-12. PubMed ID: 10945310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
